Data readouts planned for CLN-978 across all three autoimmune indications in 2026, including single dose and repeat dosing data Company to complete monotherapy expansion cohorts to determine recommend ...
Zenas anticipates submitting a Biologics License Application (BLA) to the FDA in the second quarter of 2026 and a Marketing ...
An implantable bioartificial kidney being developed by The Kidney Project – a nationwide collaboration led by Bangladeshi American Professor Shuvo Roy of U.C. San Francisco and Dr. William Fissell of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback